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The WASp homologue Las17p functions with the WIP homologue
End5p/verprolin and is essential for endocytosis in yeast
Suniti N. Naqvi*, Regina Zahn*, David A. Mitchell†, Brian J. Stevenson‡§
and Alan L. Munn*
Several end mutations that block the internalisation
step of endocytosis in Saccharomyces cerevisiae also
affect the cortical actin cytoskeleton [1]. END5 encodes
a proline-rich protein (End5p or verprolin) required for a
polarised cortical actin cytoskeleton and endocytosis
[2,3]. End5p interacts with actin [4], but its exact
function is not yet known. To help elucidate End5p
function, we sought other End5p-interacting proteins
and identified the LAS17/BEE1 gene (encoding the
yeast homologue of the human Wiskott–Aldrich
Syndrome protein, WASp) as a high-copy-number
suppressor of the temperature-sensitive growth and
endocytic defects of end5-1 cells (carrying a frameshift
mutation affecting the last 213 residues of End5p).
LAS17 is unable to suppress a full deletion of END5
(end5∆), however, suggesting that the defective End5-
1p in end5-1 mutants may be stabilised by Las17p. The
amino terminus of Las17p interacts with the carboxyl
terminus of End5p in the yeast two-hybrid system and
similar interactions have been shown between WASp
and a mammalian End5p homologue, WASp-interacting
protein (WIP) [5]. As las17∆ deletion mutants are
blocked in endocytosis, we conclude that Las17p and
End5p interact and are essential for endocytosis.
Addresses: *Institute of Molecular Agrobiology, 1 Research Link,
National University of Singapore, Singapore 117604, Republic of
Singapore. †Institute of Molecular Biology, University of Oregon,
Eugene, Oregon 97403-1229, USA. ‡Department of Biochemistry,
Biozentrum of the University of Basel, Klingelbergstrasse 70, CH-4056
Basel, Switzerland. 
Present address: §Novartis Pharma AG, CH-4002 Basel, Switzerland.
Correspondence: Alan L. Munn
E-mail: alan@ima.org.sg
Received: 15 April 1998
Revised: 18 June 1998
Accepted: 13 July 1998
Published: 17 August 1998
Current Biology 1998, 8:959–962
http://biomednet.com/elecref/0960982200800959
© Current Biology Publications ISSN 0960-9822
Results and discussion
To identify genes that can, in high copy number, suppress
the temperature-sensitivity of end5-1 cells, we transformed
these cells (AMY66) with a high copy number (2µ) yeast
genomic library and selected for loss of temperature-sensi-
tivity. All of the suppressor plasmids contained either
END5 or LAS17/BEE1 (Figure 1a). The smallest LAS17
insert to have suppressor activity contained no other open
reading frame. LAS17 encodes the yeast homologue of a
human protein defective in patients with Wiskott–Aldrich
Syndrome [6]. In these patients, haematopoietic cells have
a defective cortical actin cytoskeleton [7]. WASp is a
proline-rich protein that interacts with Cdc42p, a low mol-
ecular weight GTPase important in regulating the cortical
actin cytoskeleton [8–10].
The 2µ-LAS17 plasmid (pAM155) suppressed the tem-
perature-sensitivity of end5-1 cells (RH2075), but a cen-
tromeric plasmid containing LAS17 (cen-LAS17,
pAM161) did not have this ability. We tested the ability
of 2µ-LAS17 to suppress the temperature-sensitivity of
mutants defective in actin (act1-1, RH2150), fimbrin
Figure 1
(a) The 2µ-LAS17 plasmid suppresses the temperature-sensitivity of
end5-1, but not end5∆, cells. Ability to form colonies at 37°C was
tested for end5-1 cells (RH2075) or end5∆ cells (RH2892)
transformed with the 2µ vector (YEplac181) or with the same plasmid
containing LAS17 (2µ-LAS17, pAM155). (b) The 2µ-LAS17 plasmid
suppresses the fluid-phase endocytosis defect of end5-1 cells.
Accumulation of the endocytic marker dye lucifer yellow in the vacuole
at 37°C was assayed in end5-1 cells transformed with the 2µ vector or
with 2µ-LAS17. The same field of cells is shown with differential
interference contrast (DIC) optics to highlight the vacuole (appears as
an indentation) and with fluorescein isothiocyanate (FITC) fluorescence
optics to visualise lucifer yellow.
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(sac6∆, RH2651), and the products of the SLA1 (sla1∆,
RH2546), END3 (end3-1, RH1623; end3∆, RH1995), and
END4/SLA2 (end4-1, RH1597; end4∆, RH1965) genes, all
of which are required for endocytosis ([11–14]; A. Wesp,
H. Riezman, unpublished data). In addition, we tested for
suppression of the temperature-sensitivity of cdc42-1
(WAY299) [15], because mammalian WASp binds mam-
malian Cdc42p. Suppression of temperature-sensitivity
was complete for end5-1, weak for end3-1, and absent for
the other mutants tested; 2µ-END5 (pAM160) was also
found to be unable to suppress temperature-sensitivity
for any of the above mutants except end5-1 (and end5∆,
see below). Using the endocytic marker dye lucifer
yellow, 2µ-LAS17 was shown to be able to restore endocy-
tosis to end5-1 cells at 37°C (Figure 1b), but not at 24°C
(data not shown).
To test whether the cytoskeletal defect of end5-1 cells
could be corrected by LAS17, end5-1 cells bearing
2µ-LAS17 were grown at 24°C and then either left at 24°C
or shifted to 37°C. F actin was visualised by staining with
rhodamine-labelled phalloidin (Figure 2a). Although the
abnormal size of end5-1 cells at 37°C was corrected by
2µ-LAS17, there was no obvious change in cortical actin
patch distribution at 24°C or 37°C. Some abnormalities
within cortical actin patches in end5-1 mutants may have
been corrected without a restoration of normal localisation.
When the same experiment was carried out on wild-type
cells carrying 2µ-LAS17 (Figure 2b), the distribution of
cortical actin patches was found to be perturbed in a tem-
perature-dependent manner, and this effect of LAS17 may
explain the lack of suppression seen in Figure 2a.
As End5p and Las17p are both unusually proline-rich, we
tested whether overexpression of Las17p can functionally
replace End5p. Neither temperature-sensitivity nor endo-
cytosis were corrected in end5∆ cells transformed with
2µ-LAS17 (Figure 1a and data not shown), suggesting that
the correction of defects in end5-1 cells relies on residual
activity of mutant End5-1p. Characterisation of the end5-1
gene showed that it has a frameshift mutation after codon
604 (of 818), leading to mistranslation for 146 codons
before termination.
Las17p has been shown to localise to cortical actin patches
[6]. To determine the localisation of End5p, we used the
gene for green fluorescent protein (GFP) fused to the last
codon of intact END5. When carried on a centromeric
plasmid this END5–GFP construct is partially functional
(see Materials and methods; data not shown). End5p–GFP
can be seen in live cells in patches that are concentrated in
small buds and putative bud sites like cortical actin
patches (data not shown). In double-labelling immunoflu-
orescence experiments, colocalisation of End5p–GFP and
F actin to some, but not all, cortical patches was observed
(Figure 2c). 
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Figure 2
(a) The 2µ-LAS17 plasmid does not restore a polarised distribution of
cortical actin patches to end5-1 cells. The distribution of F actin in end5-
1 cells transformed with the 2µ vector or with 2µ-LAS17 was visualised
by staining fixed cells with rhodamine-labelled phalloidin. Cells were kept
at 24°C or shifted to 37°C for 2 h before fixation. Note that the abnormal
cell size seen for end5-1 cells after shift to 37°C is corrected by 
2µ-LAS17, even though a polarised distribution of cortical actin patches
is not restored. (b) The 2µ-LAS17 plasmid disrupts the polarised
distribution of cortical actin patches in wild-type (WT) cells. The
distribution of F actin in wild-type cells (RH1800) carrying the 2µ vector
or carrying 2µ-LAS17 was examined as in (a). (c) End5p–GFP localises
to some, but not all, cortical actin patches. Shown are end5-1 cells
expressing a partially functional End5p–GFP fusion protein from a
centromeric plasmid (pAM162) double-stained with rhodamine-
conjugated phalloidin and with rabbit anti-GFP antibodies and FITC-
conjugated goat anti-rabbit IgG secondary antibodies. Cells were
visualised using rhodamine-specific (phalloidin, upper panels) or FITC-
specific (anti-GFP, lower panels) light filters, respectively. A few of the
End5p–GFP patches do not colocalise with cortical actin patches.
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Deletion of the LAS17 gene was shown to block fluid-
phase endocytosis (Figure 3). Like end5 cells, las17∆ cells
are temperature-sensitive (data not shown) and the
2µ-END5 construct did not suppress their temperature-
sensitivity. To determine the phenotype of end5∆ las17∆
cells, we crossed a las17∆ strain to an end5∆ strain and iso-
lated recombinant haploid spores. Whereas las17∆ and
end5∆ spores formed colonies at 24°C, the las17∆ end5∆
spores germinated but formed only microcolonies (see
Supplementary material published with this article on the
internet), showing that some functions of End5p and
Las17p in growth are redundant.
Recently, a human gene encoding a proline-rich WASp-
interacting protein (WIP) was isolated using a yeast two-
hybrid screen [5]. WIP and End5p share a short stretch of
high homology in their amino-terminal domains (in the
putative actin-binding motif) and some homology in the
remainder of the proteins [5] (see Supplementary mater-
ial). Testing WIP deletions for interaction with WASp
revealed that the carboxy-terminal 126 residues of WIP
are required for binding to WASp [5]. WIP could be a
human homologue of End5p. If so, it is interesting that
the region missing in end5-1 shows some homology to that
region in WIP which is required for interaction with
WASp. It is possible that the mutant protein encoded by
end5-1 interacts poorly with Las17p and overexpression of
Las17p is necessary to produce sufficient interaction. We
tested whether full-length Las17p and End5p interact in
the yeast two-hybrid system [16] and found that they
interact strongly. We then tested interactions between dif-
ferent parts of Las17p and End5p and showed that, in an
analogous manner to WIP and WASp, the amino terminus
of Las17p interacts with the carboxyl terminus of End5p
(Table 1).
We have identified LAS17 as a gene which, in high copy
number, can suppress the growth defects and endocytosis
defect of end5-1 mutants. We suggest that End5p and
Las17p form a complex that plays a crucial role in endocy-
tosis based on the following observations: Las17p and
End5p both localise to cortical actin patches; Las17p and
End5p are each required for endocytosis; suppression by
2µ-LAS17 relies on residual End5-1p function; and Las17p
interacts with End5p in the yeast two-hybrid system. By
analogy to the interaction of human WASp with WIP,
interaction of Las17p and End5p may normally involve
interaction of the amino-terminal domain of Las17p with
the carboxy-terminal domain of End5p.
Materials and methods
Strains, growth conditions, genetic methods, and manipulation
of DNA
Standard methods and media for yeast growth, sporulation and tetrad
analysis were used [17]. All DNA manipulations were as described
[18]. AMY66 is a haploid derived from a cross of RH2075 to the wild-
type ade2 strain RH2878. The high-copy-number suppressor screen
involved transformation of a yeast genomic DNA library (a gift of
M.I. Geli, A. Wesp and H. Riezman, University of Basel) carried in the
ADE2 2µ vector pASZ12 (a gift of P. Linder, University of Geneva) into
AMY66 and selection for growth at 37°C on SD selective medium.
Plasmids present in the resulting colonies were isolated, amplified in
Escherichia coli and retransformed into AMY66 to confirm that sup-
pression is conferred by the plasmid.
Plasmid construction
A 3 kb BamHI–SphI fragment (derived from the smallest library clone,
pAM150) which contains the promoter and coding region of LAS17 was
subcloned into the centromeric vector YCplac111 [19] and the 2µ-
based vector YEplac181 [19] to create plasmids pAM161 and pAM155,
respectively. The las17∆::LEU2 and las17∆::URA3 alleles have the DNA
sequence between base pairs 42 and 1863 of the LAS17 open reading
frame replaced by LEU2 or URA3, respectively. The end5∆::URA3 allele
has the entire open reading frame of END5 from the upstream NotI site
to the downstream NcoI site replaced by URA3.
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Figure 3
LAS17 is essential for fluid-phase endocytosis in yeast. Lucifer yellow
accumulation assays were performed at 24°C on wild-type cells
(IDY19) and on an isogenic las17∆ strain (IDY166) transformed with a
centromeric vector (YCplac111) or with the same plasmid containing
LAS17 (cen-LAS17, pAM161). The same fields of cells are shown
with DIC optics to visualise the vacuoles (upper panels) and with FITC
fluorescence optics to visualise lucifer yellow (lower panels).
las17∆ las17∆ + cen-LAS17
DIC
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Table 1
The carboxyl terminus of End5p interacts with the amino
terminus of Las17p.
Activation domain Binding domain β-gal activity
fusion fusion in Miller units
End5p 1–816 – 0.13
Las17p 2–266 – 0.079
– End5p 480–816 0.11
– Las17p 2–633 0.15
End5p 1–816 Las17p 2–633 80.08
Las17p 2–266 End5p 480–816 146.05
Interaction between End5p and Las17p was tested using the yeast
two-hybrid system. β-galactosidase (β-gal) activity was assayed to
assess the strength of the interaction. Data shown here represent an
average of three independent assays.
We constructed an END5–GFP gene fusion as follows: the S65T
mutant GFP gene [20] (provided by R. Tsien, HHMI, UC San Diego)
was cloned into YCplac111 to yield pAM158. The END5 gene (lacking
its termination codon) was then ligated in-frame and upstream of the
GFP gene in pAM158 to obtain pAM162, which complements the tem-
perature-sensitivity of end5-1 (RH2075) but not end5∆ (RH2892),
while pAM158 complements neither.
2µ-END5 (pAM160) was made by subcloning a 3.4 kb HindIII–BamHI
fragment containing the promoter and entire coding region of END5
from pEND5.1 into YEplac181.
Microscopy
Fluorescence microscopy was performed using a Leica DMLB fluores-
cence microscope and images were captured either digitally, using an
Optronix DEI-470T cooled charge-coupled device camera (Leica Pte.
Ltd, Singapore), or on Kodak TMAX-400 film, using a 35 mm film
camera. Cells were fixed with formaldehyde for 30 min at the tempera-
ture of growth before staining. F actin was visualised by staining with
rhodamine–phalloidin (Sigma) as described [21]. 
For immunofluorescence, end5-1 cells (RH2075) transformed with
pAM162 were grown in SD medium at 24°C, fixed, and stained with
rabbit polyclonal anti-GFP antibodies (a gift from J. Kahana and
P. Silver, Dana Farber Cancer Institute, Boston, MA) followed by FITC-
conjugated donkey anti-rabbit IgG antibodies (Jackson Immunore-
search Laboratories) and rhodamine–phalloidin, using standard
procedures. Stained cells were visualised using FITC- and rhodamine-
specific light filters. 
Lucifer yellow uptake assay
Assays for measuring fluid-phase endocytosis of Lucifer yellow were
performed at 24°C or 37°C as described [22]. 
Yeast two-hybrid interaction test
Yeast two-hybrid interactions [16] were measured using the method
and kit supplied by Clontech Laboratories. 
Supplementary material
Additional materials and methods, the tables of yeast strains and plas-
mids used in this study, the genetic data showing synthetic lethality of
the end5∆ and las17∆ mutations, and the amino-acid sequence com-
parison of End5p and WIP are published with this article on the internet.
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Materials and methods
Construction of the END5–GFP fusion
The primers used for amplifying the GFP gene were 5′GFPC-BamHI
(5′-GATAGGATCCATGAGTAAAGGAG-3′) and 3′GFP-SmaI (5′-
GCGCGCCCCGGGTCATTTGTATAGTTCATCCAT-3′). Amplification
with these primers creates a BamHI site immediately before the GFP
start codon. The BamHI–SmaI fragment was ligated into YCplac111 to
make pAM158. A HindIII–SalI fragment derived from pEND5.1 provided
the 5′ upstream regulatory sequences and amino-terminus-encoding
half of the END5 open reading frame. The primers used for amplifying
the carboxyl-terminus-encoding half of the END5 open reading frame
were E5F2 (5′-GCTCCGCCTCCACCACCAC-3′) and E5C BamHI (5′-
ATGGAGGGATCCTCGCGTAAAT-3′). Amplification using these
primers removes the termination codon of END5 and adds a BamHI site
at this position. The fragment encoding the carboxyl terminus of END5
was digested with SalI and BamHI and ligated with a HindIII–SalI frag-
ment (derived from pEND5.1) encoding the amino terminus of END5 to
reconstruct a complete END5 gene lacking only the termination codon.
This was then ligated with pAM158 cut with HindIII and BamHI to place
END5 upstream of, and in frame with, the GFP gene.
Sequence of end5-1
The END5 and end5-1 genes were amplified from wild-type (RH1800)
and end5-1 (RH2075) cells, respectively, using Pfu polymerase (Strat-
agene). Primers used to amplify the genes were END5 N (5′-AAC-
CGTTTGTTGAAGAAGCCTACC-3′) and END5 C
(5′-TCACAGCGAAAAGGACGGGAAGCT-3′). The PCR products
were cloned into the pCR-script SK+ cloning vector (Stratagene).
Several different clones of END5 and end5-1 were sequenced using
an Omni base Sequencing Kit (Promega).
Yeast two-hybrid interaction test
Activation domain fusion constructs pAM173 (End5p 1–816 in
pB42AD) and pAM174 (Las17p 2–266 in pB42AD) and LexA DNA-
binding domain fusion constructs pAM175 (End5p 480–816 in
pLexA) and pAM178 (Las17p 2–633 in pLexA) were used to transform
EGY48 individually and in combinations. The DNA fragments contained
in the two-hybrid fusion constructs were obtained by PCR amplification
of the fragments using primers containing appropriate restriction sites.
Supplementary material
Figure S1
End5p shows amino-acid sequence homology to WIP, a human
WASp-interacting protein. An alignment is shown between the amino-
acid sequences encoded by S. cerevisiae END5/VRP1 (Genbank
accession number X87806) and human WIP (AF031588). Identical
residues are shaded in black and conservative substitutions in grey. 
END5   1 MAGAPAP PPPPPPPA LGGS...APKPAKSVMQG RDALLGD IRK GMKLKKA
WIP    1 .MPVPPP PAPPPPPT FALANTEKPTLNKTEQAG RNALLSD ISK GKKLKKT
END5  48 ETNDRSAPIV......GGGVVSSASGS SGTVSSKGPSMSAPPIPGMGAPQ
WIP   51 VTNDRSAPILDKPKGAGAGGGGGGFGG GGGFGGGGGGGGGGSFGGGGPPG
END5  92 L GDIL AGGIPKLKHINNNASTKPSPSASAPPIPGAV PSV AAPPIPNAPLS
WIP  101 L GGLF QAGMPKLRSTANRDND..SGGSRPPLLPPGG RST SAKPFS.....
END5 142 PAPAVP SIPSSSAPPIPDIPSSAAP PIPIVPSSPAP PLPL SGASAPKVPQ
WIP  144 P....P SGPGR..FPVPSPGHRSGP PEPQRNRMP.P PRPD VGSKPDSIPP
END5 192 N RPH MPS VR PAHRSHQRKSSNISLPSVSAP PLPSASLPTHVSNPPQ APPP
WIP  187 P VPS TP. .R PIQSSLHNRGS.........P PVPGG.........PR QPSP
END5 242 PPTPTIGLDSKNIKPTDNAVSP PSSEVPAGGLPFLAEINA RRSERGAVEG
WIP  217 GPTP.................P P...FPG.........N. .R...GTALG
END5 292 VSSTKIQTENHKSP SQPP LPS SAPPIPTSH APPLPPTAPPPPSLPNVTSA
WIP  233 GG..........SI RQSP LSS SSP...FSN RPPLPPT....P........
END5 342 P KKATSAPAPPPPPLPAAMSSASTNSVKATPVP PTLAPPLPNTTSVPPN K
WIP  257 . SRALDDKPPPPP...................P PVGNRPSIHREAVPP. .
END5 392 ASSMPAPPPPPPPP PGAFSTSSALSASSIPL APLPPPPPPSVATSVPS AP
WIP  285 ......PPPQNNKP P....VPSTP.RPSAPH RPHLRPPPP....SRPG PP
END5 442 PPP PTLTTNK PSASSKQS KISSSSSSSAVT PG GPLPFLAEIQKKRDDRFV
WIP  321 PLP PSSSGND ETPRLPQR NLSLSSS....T P. .PLP..............
END5 492 VGGDTGYTTQDKQEDVIGSSKDDNVRPSPIS PSINPPKQSSQNGMSFLDE
WIP  350 ..............................S PGRSGP.............
END5 542 IESKLHKQTSSNAFNAPPPHTDAMAPPLPPSAPPPPITSLPTPTASGDDH
WIP  357 ...............LPPP.........PSERPPPPVR............
END5 592 T NDKSETVLGMKKAKAPAL PGHVPPPP VPPVLSDDSKNNVPAASLLHDVL
WIP  371 . .DP............PGR SGPLPPP. .PPVSRNGS.........TSRAL
END5 642 PSSNLEKPPSPPVAAAPPL PTFSAPSLPQQSVSTSIPSP PPVAPTLSVRT
WIP  397 P.............ATPQL PSRSGVDSPR.....SGPRP P.....LPP..
END5 692 ET ESISKNPTKSPPPPPS PSTMD TGTSNS PSKNLKQRLFSTGGSTLQHKH
WIP  422 DR PSAG.....APPPPPP STSIR NGFQDS PCEDEWESRFYFHPISDLPPP
END5 742 NTHTNQPDVDVGRYTIGGSNSIVGAKS GNERIVIDDSRFKWTNVSQMPKP
WIP  467 EPYVQTTKSYPSKLARNES......RS GS.......NRRERGGPPLPPIP
END5 792 RPFQNKTKLYPSGKGSSVPLDLTLFT
WIP  504 R......................... Current Biology   
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Table S2
Yeast strains used in this study.
Name Genotype Source
AMY25 MATα /MATa his3/HIS3 his4/HIS4 leu2/leu2 ura3/ura3 lys2/LYS2 This study
trp1/TRP1 las17∆::LEU2/LAS17 end5∆::URA3/END5 bar1/BAR1
AMY66 MATα his3 his4 leu2 ura3 ade2 end5-1 bar1 This study
RH1800 MATa his4 leu2 ura3 bar1 H. Riezman
RH1597 MATa his4 leu2 ura3 end4-1 bar1 H. Riezman
RH1623 MATa his4 leu2 ura3 end3-1 bar1 H. Riezman
RH1965 MATa his4 leu2 ura3 lys2 end4∆::LEU2 bar1 H. Riezman
RH1995 MATa his4 leu2 ura3 end3∆::URA3 bar1 H. Riezman
RH2075 MATα his4 leu2 ura3 end5-1 bar1 H. Riezman
RH2076 MATa his4 leu2 ura3 trp1∆::URA3 end5-1 bar1 H. Riezman
RH2150 MATa his4 leu2 lys2 act1-1 bar1 H. Riezman
RH2546 MATa ura3 lys2 sla1∆::URA3 bar1 H. Riezman
RH2651 MATα his3 leu2 ura3 trp1 sac6∆::URA3 (bar1?) H. Riezman
RH2878 MATa his3 leu2 ura3 lys2 ade2 bar1 H. Riezman
RH2892 MATa his4 leu2 ura3 lys2 end5∆::URA3 bar1 H. Riezman
RH2893 MATα his4 leu2 ura3 lys2 end5∆::URA3 bar1 H. Riezman
WAY299 MATα his3 leu2 ura3 lys2 trp1 cdc42-1 bar1∆::LYS2 A. Wesp
IDY19 MATa his3 leu2 ura3 trp1 mfa2∆:: FUS1:lacZ G. Sprague
IDY166 MATa his3 leu2 ura3 trp1 las17∆::URA3 This study
IDY223 MATa his3 leu2 ura3 trp1 las17∆::LEU2 This study
EGY48 MATα his3 ura3 trp1 LexAop(x6)-LEU2 Clontech
Table S1
The end5∆ and las17∆ mutations exhibit synthetic lethality.
Tetrad class Parental ditype Tetratype Non-parental ditype Total
Phenotype of spores 2 Leu+ Ura– 1 Leu+ Ura– 2 Leu– Ura–
2 Leu– Ura+ 1 Leu– Ura+ 2 inviable
1 Leu– Ura–
1 inviable
Genotype of spores 2 las17∆ END5 1 las17∆ END5 2 LAS17 END5
2 LAS17 end5∆ 1 LAS17 end5∆ 2 las17∆ end5∆ (inviable)
1 LAS17 END5
1 las17∆ end5∆ (inviable)
Number of tetrads 9 20 9 38
An end5∆::URA3 strain (RH2893) was crossed with a las17∆::LEU2 strain (IDY223) and the resulting diploid (AMY25) was sporulated. A total of
38 tetrads were dissected and the genotypes of the spores scored. 
Supplementary material S3
Table S3
Plasmids used in this study.
Name Description Source
pAM150 Library clone: pASZ12 containing LAS17 This study
pASZ12 2µ-containing ADE2 vector P. Linder
YEplac181 2µ-containing LEU2 vector [19]
YCplac111 ARS-CEN containing LEU2 vector [19]
pEND5.1 END5 in YCplac111 [3]
pCR-script SK+ ApR cloning vector Stratagene
pEND5 END5 carried in pCR-Script SK+ This study
pend5-1 end5-1 carried in pCR-Script SK+ This study
pAM155 LAS17 under its own promoter in YEplac181 This study
pAM158 GFP in YCplac111 This study
pAM160 END5 under its own promoter in YEplac181 This study
pAM161 LAS17 under its own promoter in YCplac111 This study
pAM162 END5 fused with GFP in pAM158 This study
pLexA Cloning vector for DNA-binding domain fusion constructs Clontech
pB42AD Cloning vector for activation domain fusion constructs Clontech
pAM173 pB42AD expressing End5p1–816 This study
pAM174 pB42AD expressing Las17p2–266 This study
pAM175 pLexA expressing End5p480–816 This study
pAM178 pLexA expressing Las17p2–633 This study
